Title: Involvement of insulin signalling pathway in methamphetamine-induced hyperphosphorylation of Tau.
Journal: Toxicology 20180901
Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Journal: The Biochemical journal 20130415
Title: Roles of glycogen synthase kinase 3 in Alzheimer's disease.
Journal: Current Alzheimer research 20120901
Title: Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20120523
Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111101
Title: Identification of new inhibitors of protein kinase R guided by statistical modeling.
Journal: Bioorganic & medicinal chemistry letters 20110701
Title: GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Journal: Platelets 20110101
Title: A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20071218
Title: Synthetic small molecules that control stem cell fate.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20030624
Title: Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Journal: Diabetes 20000201
Title: Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Journal: Diabetes 19990801
Title: Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America 19930815
Title: Ding S, et al. Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7632-7. Epub 2003 Jun 6.
Title: Wang W, et al. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats. Mol Neurobiol. 2016 Dec;53(10):7028-7036. Epub 2015 Dec 15.
Title: Chen YQ, et al. Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human γδT cells against colon cancer. Exp Cell Res. 2017 Nov 16. pii: S0014-4827(17)30587-6.
